Renaissance Technologies's LEGN Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 402,800 shares of Legend Biotech Corporation (LEGN) worth $8.76 M, representing 0.01% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in LEGN, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 890,000 shares. Largest reduction occurred in Q4 2025, reducing 440,400 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Legend Biotech Corporation (LEGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Legend Biotech Corporation (LEGN) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -440,400 | Reduce 52.23% | 402,800 | $21.74 |
| Q3 2025 | +186,900 | Add 28.48% | 843,200 | $32.61 |
| Q2 2025 | -54,600 | Reduce 7.68% | 656,300 | $35.49 |
| Q1 2025 | -197,200 | Reduce 21.72% | 710,900 | $33.93 |
| Q4 2024 | +890,000 | Add 4917.13% | 908,100 | $32.54 |
| Q3 2024 | +18,100 | New Buy | 18,100 | $48.73 |
| Q1 2024 | -122,000 | Sold Out | 0 | $0.00 |
| Q4 2023 | +21,800 | Add 21.76% | 122,000 | $60.17 |
| Q3 2023 | +86,100 | Add 610.64% | 100,200 | $67.17 |
| Q2 2023 | -27,200 | Reduce 65.86% | 14,100 | $0.07 |
| Q1 2023 | +10,400 | Add 33.66% | 41,300 | $0.05 |
| Q4 2022 | -39,300 | Reduce 55.98% | 30,900 | $0.05 |
| Q3 2022 | +70,200 | New Buy | 70,200 | $40.80 |
| Q2 2022 | -181,100 | Sold Out | 0 | $0.00 |
| Q1 2022 | +181,100 | New Buy | 181,100 | $36.34 |
| Q3 2021 | -60,800 | Sold Out | 0 | $0.00 |
| Q2 2021 | +60,800 | New Buy | 60,800 | $41.05 |
Renaissance Technologies's Legend Biotech Corporation Investment FAQs
Renaissance Technologies first purchased Legend Biotech Corporation (LEGN) in Q2 2021, acquiring 60,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Legend Biotech Corporation (LEGN) for 17 quarters since Q2 2021.
Renaissance Technologies's largest addition to Legend Biotech Corporation (LEGN) was in Q4 2024, adding 908,100 shares worth $29.55 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 402,800 shares of Legend Biotech Corporation (LEGN), valued at approximately $8.76 M.
As of the Q4 2025 filing, Legend Biotech Corporation (LEGN) represents approximately 0.01% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in Legend Biotech Corporation (LEGN) was 908,100 shares, as reported at the end of Q4 2024.